Related Experiment Video
Updated: Feb 8, 2026

Characterizing Mutational Load and Clonal Composition of Human Blood
Published on: July 11, 2019
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Pradeep Natarajan1,2,3, Siddhartha Jaiswal4,2,3, Sekar Kathiresan5
1Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Boston (P.N., S.K.). pnatarajan@mgh.harvard.edu.
Insights
Age is a key factor in atherosclerotic cardiovascular disease. Clonal hematopoiesis, common in older adults, increases risks for both blood cancers and cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Hematology
- Genetics
Background:
- Age is the primary prognostic factor for atherosclerotic cardiovascular disease (ASCVD).
- Somatic mutations in blood cells, known as clonal hematopoiesis, are increasingly prevalent with age.
- Over 10% of adults over 70 are affected by clonal hematopoiesis.
Purpose of the Study:
- To review literature on clonal hematopoiesis and its association with ASCVD.
- To examine the causal link between clonal hematopoiesis and atherosclerotic cardiovascular disease.
Main Methods:
- Review of existing scientific literature.
- Analysis of exome sequence data.
- Examination of studies on clonal selection and expansion in hematopoietic stem cells.
Main Results:
- Clonal hematopoiesis is common in older adults and increases with age.
- Individuals with clonal hematopoiesis face higher risks of hematologic malignancy.
- Clonal hematopoiesis is associated with an elevated risk of atherosclerotic cardiovascular disease.
Conclusions:
- Clonal hematopoiesis is a significant risk factor for atherosclerotic cardiovascular disease.
- Understanding the mechanisms of clonal expansion in hematopoietic stem cells is crucial.
- Further research is needed to elucidate the causal relationship between clonal hematopoiesis and ASCVD.
Abstract:
The most important prognostic factor for atherosclerotic cardiovascular disease is age, independent of all other recognized risk factors. Recently, exome sequence analyses showed that somatic mutations in blood cells, a process termed clonal hematopoiesis, are common and increase in prevalence with age, with at least 1 in 10 adults older than 70 years affected. Carriers of clonal hematopoiesis have been shown to be not only at heightened risk for hematologic malignancy but also at increased risk for atherosclerotic cardiovascular disease. Here, we review the prior literature of clonal selection and expansion of hematopoietic stem cells and the evidence supporting its causal association with atherosclerotic cardiovascular disease.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Hematopoiesis
Mutations
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Somatic to iPS Cell Reprogramming

